<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04734158</url>
  </required_header>
  <id_info>
    <org_study_id>MiniaUN</org_study_id>
    <nct_id>NCT04734158</nct_id>
  </id_info>
  <brief_title>CORNEAL EPITHELIAL MAPPING IN DIABETICS</brief_title>
  <official_title>EVALUATION OF CORNEAL EPITHELIAL THICKNESS MAPPING IN DIABETIC PATIENTS USING ANTERIOR SEGMENT OPTICAL COHERENCE TOMOGRAPHY AND ITS CORRELATION TO MACULAR THICKNESS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Minia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Minia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The corneal epithelium is the outermost layer that covers the front of the eye; it not only&#xD;
      functions as a barrier that blocks the passage of foreign material, but also plays an&#xD;
      important role in maintaining high optical quality. The stem cells in the basal layer of the&#xD;
      limbal epithelium hold a physiological significance in the renewal and metabolism of corneal&#xD;
      epithelium, particularly under stressful situations.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The cornea in diabetic patients suffers from cellular dysfunction and dysfunctional repairal&#xD;
      mechanisms, which include recurrent erosions, delayed wound healing, ulcers, and edema. In&#xD;
      addition and undoubtedly related to epithelial dysfunction, alterations in epithelial&#xD;
      basement membrane occur.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 12, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>corneal epithelial thickness</measure>
    <time_frame>2 years</time_frame>
    <description>corneal thickness in diabetics using OCT</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">153</enrollment>
  <condition>Cornea Epithelial Mapping</condition>
  <arm_group>
    <arm_group_label>Healthy control</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Diabetics with macular edema</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Diabetics without macular edema</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>corneal imaging</intervention_name>
    <description>corneal imaging using AS-OCT</description>
    <arm_group_label>Diabetics with macular edema</arm_group_label>
    <arm_group_label>Diabetics without macular edema</arm_group_label>
    <arm_group_label>Healthy control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        It's a prospective cross section study. 159 eyes of 159 patients will be involved in this&#xD;
        study, divided into three groups: (Group A) 53 eyes of diabetic patients with diabetic&#xD;
        macular edema, (Group B) 53 eyes of diabetic patients without macular edema and (group C)&#xD;
        53 eyes of age matched control.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. The patients aged between 40- 60 years old of both genders.&#xD;
&#xD;
          2. The patients in (Group A) should be diabetics for more than 10 years and free from any&#xD;
             other systemic diseases with diabetic macular edema (by OCT).&#xD;
&#xD;
          3. The patients in (Group B) should be diabetics for more than 10 years and free from any&#xD;
             other systemic diseases without diabetic macular edema (by OCT).&#xD;
&#xD;
          4. The patients in (Group C) should be free of any systemic diseases and normal macular&#xD;
             thickness (by OCT)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Previous history of any intraocular surgery, intravitreal injection, laser or&#xD;
             refractive surgery.&#xD;
&#xD;
          2. Ocular surface disorders (e.g. dry eye) or any corneal pathology.&#xD;
&#xD;
          3. Corneal scars or epithelial dystrophies.&#xD;
&#xD;
          4. Use of any topical medications.&#xD;
&#xD;
          5. Elevated IOP, pregnancy or lactation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hosny A Zein</last_name>
    <phone>01014145780</phone>
    <email>hosnyzein@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Minia University</name>
      <address>
        <city>Minya</city>
        <zip>61111</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hosny A Zein, MD</last_name>
      <phone>01014145780</phone>
      <email>hosnyzein@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 28, 2021</study_first_submitted>
  <study_first_submitted_qc>January 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 2, 2021</study_first_posted>
  <last_update_submitted>January 28, 2021</last_update_submitted>
  <last_update_submitted_qc>January 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Minia University</investigator_affiliation>
    <investigator_full_name>Hosny Ahmed Zein</investigator_full_name>
    <investigator_title>DR. HOSNY AHMED ZEIN</investigator_title>
  </responsible_party>
  <keyword>cornea epithelium OCT diabetes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Corneal Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

